Neurofibromatosis Type 1 Clinical Trials in Washington D.C., District of Columbia
2 recruitingWashington D.C., District of Columbia
Showing 1–2 of 2 trials
Recruiting
Not Applicable
A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)
Neurofibromatosis Type 1
National Cancer Institute (NCI)70 enrolled2 locationsNCT06507748
Recruiting
Phase 2
A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
Neurofibromatosis Type 1
Healx Limited25 enrolled13 locationsNCT06541847